Back to results
US 2020/0392250 A1Published application
Hexokinase 2-specific inhibitor in acute central nervous system injury disease
AssigneeGuangzhou Cellprotek Pharmaceutical Co., Ltd.
InventorsGuangmei YAN, Wei YIN, Yuan LI, Bingzheng LU, Longxiang SHENG
Life of this patent
Estimating the term…
Abstract
Provided are applications of a hexokinase 2-specific inhibitor in preparing a medicament for preventing and treating acute central nervous system injury.
Claims10
A method for treatment of acute central nervous system injury comprising administering to a subject a pharmaceutically effective amount of a hexokinase 2-specific inhibitor.
A method for treatment of acute central nervous system injury comprising administering to a subject a pharmaceutically effective amount of a composition comprising hexokinase 2-specific inhibitor.
Dependencies are inferred from the claim text.